Landlocked developing countries (LLDCs) vs Pakistan: Percentage of bloodstream infection due to methicillin-resistant
Landlocked developing countries (LLDCs)
53.8%
in 2022
Pakistan
67.1%
in 2022
Landlocked developing countries (LLDCs) rank
3rd
Pakistan rank
3rd
Percentage of bloodstream infection due to methicillin-resistant over time
- Landlocked developing countries (LLDCs)
- Pakistan
How they compare
Pakistan currently reports 67.1% against 53.8% in Landlocked developing countries (LLDCs), a difference of 13.3%.
That makes Pakistan's figure about 1.2 times Landlocked developing countries (LLDCs)'s.
The two have swapped places 4 times across 6 shared years of data; in 2017 it was Pakistan ahead.
Landlocked developing countries (LLDCs) ranks 3rd and Pakistan ranks 3rd of 4 regions.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Landlocked developing countries (LLDCs) | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.2% | 52.1% | 34.9% | Pakistan |
| 2020s | 62.2% | 73.0% | 10.8% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Landlocked developing countries (LLDCs) or Pakistan?
- Pakistan, at 67.1% against 53.8% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Landlocked developing countries (LLDCs) and Pakistan?
- 13.3%, with Pakistan ahead.
- How many years of comparable data are there for Landlocked developing countries (LLDCs) and Pakistan?
- 6 years are reported by both, from 2017 to 2022.
- How do Landlocked developing countries (LLDCs) and Pakistan rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Landlocked developing countries (LLDCs) ranks 3rd and Pakistan ranks 3rd of 4 regions.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.